Skip to main content
logo
Astria Therapeutics, Inc. (ATXS)
Jan 26, 2026 - ATXS was delisted (reason: acquired by BCRX)
12.58
0.00 (0.00%)
Inactive · Last trade price on Jan 22, 2026

Astria Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.71-----
Revenue Growth
------
Gross Profit
0.71-----
Operating Income
-136.51-111.56-67.83-53.5-30.36-37.44
Net Income
-124.03-94.26-72.89-51.83-219.35-37.3
Earnings Per Share
-2.14-1.68-2.42-3.55-24.58-12.20
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
227.72328.13246.53226.44125.5144.93
Total Debt
4.465.350.330.940.371.05
Net Cash (Debt)
223.26322.78246.2225.5125.1443.88
Net Cash Growth
-34.07%31.10%9.18%80.19%185.17%29.10%
Net Cash Per Share
3.855.758.1715.4214.0214.35

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-119.73-81.21-68.45-43.53-30.15-32.49
Capital Expenditures
-0.59-0.33-0.03-0.09-0.02-0.03
Free Cash Flow
-120.32-81.54-68.47-43.62-30.17-32.52
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
100.00%-----
Operating Margin
-19335.69%-----
Profit Margin
-17567.99%-----
FCF Margin
-17042.92%-----

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
1017.18-----